Editorial: PIVKA-II Facilitates Risk Stratification for HCC Following HCV Cure-Authors' Reply

Affiliations

• ¹ Department of Medical Sciences, Liver Unit, University of Turin, Turin, Italy.
• ² Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
• ³ Hepatology Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy.
• ⁴ Gastroenterology Unit, Città Della Salute e Della Scienza di Torino-Molinette Hospital, Turin, Italy.